An ACTH-derived heptapeptide that robustly upregulates BDNF and NGF for neuroplasticity, memory, and cognitive performance. Approved in Russia for stroke recovery, cognitive enhancement, and optic nerve disease. One of the most validated nootropic peptides in existence — backed by decades of clinical use.
Semax doesn't just temporarily boost cognition — it physically remodels neural architecture through neurotrophic factor upregulation. BDNF and NGF drive new synaptic connections, enhanced memory consolidation, and long-term cognitive resilience.
Semax is administered intranasally for direct CNS delivery. The N-Acetyl Semax (NASA) variant has enhanced potency and longer duration. Standard Semax: 200–600mcg/day. N-Acetyl Semax: up to 1200mcg/day.
Semax was developed at the Institute of Molecular Genetics, Russian Academy of Sciences — the same institute that produced Selank. It's derived from the ACTH (4-10) fragment, modified for enhanced CNS activity and metabolic stability.
Russian clinical applications include post-stroke cognitive recovery (where Semax improved recovery speed and outcomes), cognitive enhancement in healthy individuals, attention deficit conditions, and optic nerve atrophy. It has been in clinical use since the 1990s.
Genomic studies showed Semax influences over 24 genes related to neurotrophic factors, immune function, and vascular regulation in the brain. The BDNF and NGF upregulation is dose-dependent and persists beyond the administration period, suggesting lasting neuroplastic changes.
| Compound | Mechanism | Route | BDNF | Data Level |
|---|---|---|---|---|
| Semax | BDNF + NGF + Neuroprotection | Intranasal | Strong ↑ | 30yr clinical |
| Selank | GABA + BDNF + 5-HT | Intranasal | Moderate ↑ | 20yr clinical |
| Dihexa | Synaptogenesis (HGF/c-Met) | Oral | Indirect | Preclinical |
| P21 | Neurogenesis (CNTF) | SubQ/Nasal | Indirect | Preclinical |
Semax's side effect profile is manageable with proper protocol adherence. Baseline blood work before starting and periodic monitoring during use is essential.
Semax has something almost no nootropic can claim: 30 years of clinical use in a real healthcare system. Russian approval for stroke recovery, cognitive enhancement, and optic nerve disease represents validation that goes far beyond animal studies and self-experimentation. The BDNF/NGF upregulation is robust and dose-dependent, producing lasting neuroplastic changes beyond the dosing period. Pair with Selank for the Limitless Stack — cognitive performance plus emotional stability. The N-Acetyl variant (NASA) offers enhanced potency for experienced users. Intranasal, no injections, no tolerance, no dependence. If you're optimizing cognitive performance, Semax is the foundation.
Our free Protocol Guide includes the complete Limitless Stack — Semax + Selank, N-Acetyl variant guide, and cognitive tracking templates.